N. Lei et al. / Journal of Molecular Structure 1067 (2014) 220–224
221
Scheme 1. Structure of complexes 1 and 2.
The IR spectra were taken on a Vector22 Bruker spectrophotom-
eter (400–4000 cmÀ1
with KBr pellets. NMR spectra were
Synthesis of [Cd2(L2)4(CH3OH)4] (2)
)
measured on a Bruker AM 500 spectrometer. Elemental analyses
for C, H and N were performed on a Perkin–Elmer 240C analyzer.
Fluorescence spectra were recorded on a Hitachi F-4500 fluores-
cence spectrophotometer.
Complex 2 was obtained with similar procedure for synthesiz-
ing 1 by using HL2 instead of HL1. Yield: 10.7 mg (73% on the basis
of HL2). IR (KBr, cmÀ1): 3060, 2937, 2836, 1603, 1516, 1419, 1394,
1333, 1253, 1212, 1173, 1114, 1033, 837, 813, 762, 683, 625, 547,
420. Anal. Calcd. for C72H64N4O16Cd2: C, 58.98; H, 4.40; N, 3.82.
Found: C, 59.21; H, 4.38; N, 3.83%.
Synthesis of 2-(4-fluorophenyl)quinoline-4-carboxylic acid (HL1)
X-ray data collection and structure refinement
A mixture of isatin (1.18 g, 8.00 mmol), 4-fluoroacetophenone
(0.28 g, 2.00 mmol) and potassium hydroxide (2.24 g, 40.00 mmol)
in 2 mL of ethanol and 18 mL of water was refluxed for 12 h. Then
the orange solution was cooled to room temperature and then
poured into 20 mL of water. The solution was adjusted to pH 5 with
1 M HCl. The resulting brown precipitate was filtered, washed with
water and dried in vacuo to give the product. Yield: 0.31 g, 58%. IR
(KBr, cmÀ1): 3442, 3081, 2935, 2839, 1714, 1646, 1548, 1413, 1368,
1243, 1226, 1029, 860, 837, 806, 766, 696, 544, 516. 1H NMR
(500 MHz, DMSO, d): 8.63 (t, 1H), 8.42 (s, 1H), 8.35 (t, 1H), 8.26
(d, J = 8.5 Hz, 1H), 8.13(q, 1H), 7.84 (q, 1H), 7.67 (m, 1H), 7.39 (t,
1H), 7.11 (d, J = 8.5 Hz, 1H). Anal. Calcd for C16H10FNO2: C, 71.91;
H, 3.77; N, 5.24. Found: C, 72.05; H, 3.75; N, 5.26%.
Single crystals of all the complexes for X-ray diffraction analy-
ses with suitable dimensions were mounted on the glass rod. The
data were collected on a Bruker Smart Apex CCD diffractrometer
equipped with graphite-monochromated Mo K
a (k = 0.71073 Å)
radiation using a –2h scan mode at 273 K. The highly redundant
x
data sets were reduced using SAINT and corrected for Lorentz and
polarization effects. Absorption corrections were applied using
SADABS supplied by Bruker. The structure was solved by direct
methods and refined by full-matrix least-squares methods on F2
using SHELXTL-97. All non-hydrogen atoms were found in alter-
nating difference Fourier syntheses and least-squares refinement
cycles, refined anisotropically. All the hydrogen atoms bonded to
C atoms were generated geometrically and refined isotropically
using the riding model. While hydroxyl H atoms of methanol mol-
ecules were first found in the Fourier map and then fixed at their
ideal positions with O-H = 0.96 (2) Å and Uiso(H) = 1.5Ueq(O).
Synthesis of 2-(4-methoxyphenyl)quinoline-4-carboxylic acid (HL2)
Orange product HL2 was obtained with similar procedure for
synthesizing HL1 by using 4-methoxyacetophenone instead of 4-
fluoroacetophenone. Yield: 0.37 g, 66%. IR (KBr, cmÀ1): 3440,
3077, 2936, 2840, 1713, 1651, 1602, 1521, 1425, 1374, 1247,
1189, 1077, 860, 836, 812, 761, 689, 540, 519. 1H NMR
(500 MHz, DMSO, d): 8.62 (d, J = 8.5 Hz, 1H), 8.41 (s, 1H), 8.26 (d,
J = 8.5 Hz, 2H), 8.11(d, J = 8.5 Hz, 1H), 7.82 (t, 1H), 7.66 (t, 1H),
7.11 (d, J = 8.5 Hz, 2H), 3.86 (s, 3H). Anal. Calcd for C17H13NO3: C,
73.11; H, 4.69; N, 5.01. Found: C, 73.41; H, 4.67; N, 5.03%
Water
H atoms were refined with distance restraints of
O-H = 0.85 (2) Å, HÁÁÁH = 1.44 (2) Å and Uiso(H) = 1.5Ueq(O).
Bioassay conditions
The antibacterial activity of the synthesized compounds was
tested against Bacillus subtilis, Escherichia coli, Pseudomonas aeru-
ginosa and Staphylococcus aureus using MH medium (Mueller–Hin-
ton medium: casein hydrolysate 17.5 g, soluble starch 1.5 g, beef
extract 1000 mL). The IC50 (half minimum inhibitory concentra-
tions) of the test compounds were determined by a colorimetric
method using the dye MTT (3-(4,5-dimethylth-iazol-2-yl)-2,5-di-
phenyl tetrazoliumbromide). A stock solution of the synthesized
Synthesis of [Cd2(L1)4(CH3OH)4]Á1.5H2O (1)
A CH3OH solution (5 mL) of Cd(CH3COO)2Á2H2O (0.04 mmol,
10.7 mg) was added to
a CH3OH solution (10 mL) of HL1
(0.04 mmol, 10.7 mg) with stirring. The mixture was stirred for
20 min at room temperature. The resulting solution was allowed
to stand in air for three days. Colorless block-shaped crystals suit-
able for X-ray single crystal analysis were formed at the bottom of
the vessel. Yield: 9.6 mg (67% on the basis of HL1). IR (KBr, cmÀ1):
3064, 2838, 1601, 1513, 1416, 1392, 1332, 1253, 1233, 1174, 1156,
905, 840, 812, 762, 665, 624, 552, 465. Anal. Calcd. for
compound (100 lg/mL) in DMSO was prepared and graded quanti-
ties of the test compounds were incorporated in specified quantity
of sterilized liquid MH medium. A specified quantity of the med-
ium containing the compound was poured into microtitration
plates. Suspension of the microorganism was prepared to contain
approximately 105 cfu/mL and applied to microtitration plates
with serially diluted compounds in DMSO to be tested and incu-
bated at 37 °C for 24 h. After the MICs were visually determined
C68H55N4F4O13.5Cd2: C, 56.52; H, 3.83; N, 3.87. Found: C, 56.71;
H, 3.81; N, 3.89%.
on each of the microtitration plates, 50 lL of PBS (phosphate